Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY) Short Interest Update

Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY) was the recipient of a significant growth in short interest in June. As of June 15th, there was short interest totalling 400 shares, a growth of 100.0% from the May 31st total of 200 shares. Based on an average daily volume of 1,900 shares, the short-interest ratio is presently 0.2 days.

Clinuvel Pharmaceuticals Trading Down 2.5 %

Shares of CLVLY stock traded down $0.25 during trading on Friday, reaching $9.80. The company’s stock had a trading volume of 4,509 shares, compared to its average volume of 3,279. Clinuvel Pharmaceuticals has a 1-year low of $8.54 and a 1-year high of $13.55. The stock’s 50-day moving average price is $9.95 and its 200 day moving average price is $10.02.

About Clinuvel Pharmaceuticals

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP).